Increase/Decrease in Cash: The total change in cash for the company over the given period.
Oxford BioMedica (OXBDF) had Increase/Decrease in Cash of $-7.69M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$149.59M |
|
$62.81M |
|
$95.98M |
|
$245.56M |
|
$79.12M |
|
$114.43M |
|
$129.29M |
|
$208.41M |
|
$37.15M |
|
$9.55M |
|
$37.15M |
|
106.14M |
|
| Cash Flow Statement Financials | |
$4.12M |
|
$-0.27M |
|
$-11.53M |
|
$68.85M |
|
$61.16M |
|
|
Increase/Decrease in Cash |
$-7.69M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|